tetrahydrocortisone

{{chembox

| Verifiedfields = changed

| verifiedrevid = 470604200

| ImageFile=Tetrahydrocortisone.png

| ImageClass = skin-invert-image

| ImageSize=200px

| IUPACName=3α,17,21-Trihydroxy-5β-pregnane-11,20-dione

| SystematicName=(1R,3aS,3bS,5aR,7R,9aS,9bS,11aS)-1,7-Dihydroxy-1-(hydroxyacetyl)-9a,11a-dimethylhexadecahydro-10H-cyclopenta[a]phenanthren-10-one

| OtherNames=Urocortisone; 3α,5β-Tetrahydrocortisone

|Section1={{Chembox Identifiers

| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}

| ChemSpiderID = 5657

| InChI = 1/C21H32O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h12-15,18,22-23,26H,3-11H2,1-2H3/t12-,13-,14+,15+,18-,19+,20+,21+/m1/s1

| InChIKey = SYGWGHVTLUBCEM-ZIZPXRJBBU

| StdInChI_Ref = {{stdinchicite|correct|chemspider}}

| StdInChI = 1S/C21H32O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h12-15,18,22-23,26H,3-11H2,1-2H3/t12-,13-,14+,15+,18-,19+,20+,21+/m1/s1

| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}

| StdInChIKey = SYGWGHVTLUBCEM-ZIZPXRJBSA-N

| CASNo_Ref = {{cascite|changed|??}}

| CASNo=53-05-4

| ChEMBL_Ref = {{ebicite|changed|EBI}}

| ChEMBL = 1908043

| PubChem=5866

| UNII_Ref = {{fdacite|correct|FDA}}

| UNII = 5HF9TM2D15

| SMILES = O=C2[C@H]3[C@H]([C@@H]1CC[C@](O)(C(=O)CO)[C@@]1(C)C2)CC[C@@H]4C[C@H](O)CC[C@]34C

}}

|Section2={{Chembox Properties

| Formula=C₂₁H₃₂O₅

| MolarMass=364.48 g/mol

| Appearance=

| Density=

| MeltingPt=

| BoilingPt=

| Solubility=

}}

|Section3={{Chembox Hazards

| MainHazards=

| FlashPt=

| AutoignitionPt =

}}

}}

Tetrahydrocortisone, or urocortisone, also known as 3α,17α,21-trihydroxy-5β-pregnane-11,20-dione, is a steroid and an inactive metabolite of cortisone.{{cite book|author1=Thomas L. Lemke|author2=David A. Williams|title=Foye's Principles of Medicinal Chemistry|url=https://books.google.com/books?id=Sd6ot9ul-bUC&pg=PA915|date=24 January 2012|publisher=Lippincott Williams & Wilkins|isbn=978-1-60913-345-0|pages=915–}}